Pegah Golabi
About
In The Last Decade
Pegah Golabi
99 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Epidemiology 6.2k
- Hepatology 2.9k
- Endocrinology, Diabetes and Metabolism 2.6k
- Pathology and Forensic Medicine 1.0k
- Surgery 1.0k
Countries citing papers authored by Pegah Golabi
This map shows the geographic impact of Pegah Golabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pegah Golabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pegah Golabi more than expected).
Fields of papers citing papers by Pegah Golabi
This network shows the impact of papers produced by Pegah Golabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pegah Golabi. The network helps show where Pegah Golabi may publish in the future.
Co-authorship network of co-authors of Pegah Golabi
This figure shows the co-authorship network connecting the top 25 collaborators of Pegah Golabi. A scholar is included among the top collaborators of Pegah Golabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pegah Golabi. Pegah Golabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | The Global Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among Patients With Type 2 Diabetes breakdown → | 139 |
| 2 | 3 | |
| 3 | Prevalence of metabolic dysfunction‐associated steatotic liver disease in the Middle East and North Africa breakdown → | 43 |
| 4 | 23 | |
| 5 | 59 | |
| 6 | 36 | |
| 7 | 3 | |
| 8 | 43 | |
| 9 | 74 | |
| 10 | 53 | |
| 11 | 70 | |
| 12 | The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis breakdown → | 1517 |
| 13 | 13 | |
| 14 | 82 | |
| 15 | Epidemiology of chronic liver diseases in the USA in the past three decades breakdown → | 387 |
| 16 | 49 | |
| 17 | 42 | |
| 18 | 16 | |
| 19 | 15 | |
| 20 | 196 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.